Otrinazil (Xylometazoline Hydrochloride, Dexpanthenol)

Xylometazoline hydrochloride, the active ingredient in Otrinazil, is an alpha‑adrenergic agonist presented as a nasal spray for topical intranasal use. It relieves nasal congestion associated with common colds, sinusitis, and allergic rhinitis in adults and children. GNH USA supplies Otrinazil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Otrinazil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Otrinazil, a topical nasal decongestant, acts on the nasal mucosa to reduce swelling and improve airflow.

- Common cold: alleviates nasal congestion and improves breathing. - Acute sinusitis: reduces nasal passage swelling, facilitating drainage. - Allergic rhinitis: decreases nasal obstruction caused by allergic inflammation. - Nasal surgery recovery: helps maintain airway patency post‑operatively.

Side effects are generally mild and transient, reflecting local irritation or systemic absorption.

Common Side Effects: - Nasal burning or stinging sensation. - Mild nasal dryness. - Sneezing. - Transient headache. - Epistaxis (nosebleed) due to local irritation. - Cough.

Serious or Rare Side Effects: - Persistent hypertension. - Severe nasal ulceration. - Allergic reaction with rash, itching, or swelling. - Anaphylaxis. - Rebound congestion after prolonged use. - Vision changes.

When using Otrinazil, follow these safety considerations:

- Age restriction: Use  - Contraindication:  - Drug‑P​    "); -  ");  -   """"  " """ " "" " " " "" " "" " " " " " " "" " " " " " " " " " " " " " " " " 

Store "); - "); - """ """"" """"""""""

The     t  "" "".

" """""""""" ""  t """ 

  ""